The HealthVerity agreement is the latest in a series of data partnerships through which Thermo Fisher has been expanding its ...
In today's ACT Brief, we explore industry perspectives on operational and methodological shifts defining 2026, how agentic AI will augment clinical trial roles over the next two years, and Roche's ...
In a recent video interview with Applied Clinical Trials, Nick Frenzer, general manager of site solutions at Veeva Systems, discussed why eSource has remained c ...
In this video interview, Cheryl Kole, vice president of solution strategy and commercialization at Almac Clinical ...
In this Q&A, Krishna Cheriath, VP and head of clinical research digital data and AI at Thermo Fisher Scientific, examines how ...
In today's ACT Brief, we explore how user-friendly technology reduces errors and site workarounds, strategic approaches to ...
In today's ACT Brief, we examine why expanding governance layers slow digital modernization initiatives, how AI will augment ...
Long-term follow-up is a necessity for vaccine development, and is critical for establishing safety data, determining how ...
In a recent video interview with Applied Clinical Trials, Krishna Cheriath, vice president and head of clinical research ...
In a recent video compilation from Applied Clinical Trials, four industry leaders discussed the trends and inflection points ...
In this video interview, Krishna Cheriath, vice president and head of clinical research digital data and AI at Thermo Fisher ...
In today's ACT Brief, we explore why clinical trial diversity requires protocol redesign from the outset, the highest-impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results